<SEC-DOCUMENT>0001213900-21-000217-index.html : 20210104
<SEC-HEADER>0001213900-21-000217.hdr.sgml : 20210104
<ACCEPTANCE-DATETIME>20210104172828
ACCESSION NUMBER:		0001213900-21-000217
CONFORMED SUBMISSION TYPE:	8-K/A
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20201230
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Material Modifications to Rights of Security Holders
ITEM INFORMATION:		Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20210104
DATE AS OF CHANGE:		20210104

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Inmune Bio, Inc.
		CENTRAL INDEX KEY:			0001711754
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				475205835
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38793
		FILM NUMBER:		21502909

	BUSINESS ADDRESS:	
		STREET 1:		1200 PROSPECT STREET
		STREET 2:		SUITE 525
		CITY:			LA JOLLA
		STATE:			CA
		ZIP:			92037
		BUSINESS PHONE:		8589643720

	MAIL ADDRESS:	
		STREET 1:		1200 PROSPECT STREET
		STREET 2:		SUITE 525
		CITY:			LA JOLLA
		STATE:			CA
		ZIP:			92037
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K/A
<SEQUENCE>1
<FILENAME>ea132661-8ka1_inmune.htm
<DESCRIPTION>AMENDMENT NO. 1 TO FORM 8-K
<TEXT>
Document 1 - file: ea132661-8ka1_inmune.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>2
<FILENAME>ea132661ex4-1_inmune.htm
<DESCRIPTION>RIGHTS AGREEMENT, DATED AS OF DECEMBER 30, 2020, BY AND BETWEEN INMUNE BIO INC. AND VSTOCK TRANSFER, LLC
<TEXT>
Document 2 - file: ea132661ex4-1_inmune.htm

</DOCUMENT>
</SEC-DOCUMENT>